Cargando…
New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era
Microbiota is considered an independent organ with the capability to modulate tumor growth and response to therapies. In the chemo-free era, the use of new immunotherapies, more selective and effective and less toxic, led to the extension of overall survival of patients, subject to their ability to...
Autores principales: | Innao, Vanessa, Allegra, Andrea Gaetano, Musolino, Caterina, Allegra, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727716/ https://www.ncbi.nlm.nih.gov/pubmed/33255336 http://dx.doi.org/10.3390/ijms21238902 |
Ejemplares similares
-
Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs
por: Innao, Vanessa, et al.
Publicado: (2020) -
Coagulopathy and thromboembolic events in patients with
SARS-CoV-2 infection: pathogenesis and management strategies
por: Allegra, Alessandro, et al.
Publicado: (2020) -
Radioprotective Agents and Enhancers Factors. Preventive and Therapeutic Strategies for Oxidative Induced Radiotherapy Damages in Hematological Malignancies
por: Allegra, Andrea Gaetano, et al.
Publicado: (2020) -
Promising Anti-Mitochondrial Agents for Overcoming Acquired Drug Resistance in Multiple Myeloma
por: Innao, Vanessa, et al.
Publicado: (2021) -
Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma
por: Musolino, Caterina, et al.
Publicado: (2017)